172 related articles for article (PubMed ID: 23037008)
1. The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists.
Raina A; Horn ET; Benza RL
Transplantation; 2012 Nov; 94(9):885-93. PubMed ID: 23037008
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.
Neuhofer W; Pittrow D
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747
[TBL] [Abstract][Full Text] [Related]
3. Endothelin receptor antagonists -- their role in pulmonary medicine.
Boniface S; Reynaud-Gaubert M
Rev Mal Respir; 2011 Oct; 28(8):e94-e107. PubMed ID: 22099418
[TBL] [Abstract][Full Text] [Related]
4. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
5. Role of endothelin and endothelin receptor antagonists in renal disease.
Neuhofer W; Pittrow D
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.
Issa N; Kukla A; Ibrahim HN
Am J Nephrol; 2013; 37(6):602-12. PubMed ID: 23796509
[TBL] [Abstract][Full Text] [Related]
7. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
Helal I; Chan L
Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
[TBL] [Abstract][Full Text] [Related]
8. Endothelin: role in hypertension.
Schiffrin EL
Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
[TBL] [Abstract][Full Text] [Related]
9. Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection.
Knoll T; Oltersdorf J; Göttmann U; Schaub M; Michel MS; Kirchengast M; van der Woude FJ; Rohmeiss P; Braun C
Transpl Int; 2003 Jun; 16(6):425-9. PubMed ID: 12819874
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptor antagonists in preclinical models of pulmonary hypertension.
Pullamsetti SS; Schermuly RT
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():3-13. PubMed ID: 19335741
[TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction.
Kahan BD
Transplantation; 2001 Jun; 71(11 Suppl):SS52-7. PubMed ID: 11583490
[TBL] [Abstract][Full Text] [Related]
12. Endothelin plasma levels in acute graft rejection after heart transplantation.
Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
[TBL] [Abstract][Full Text] [Related]
13. Endothelin(A) receptor blockade reduces ischemia/reperfusion injury in pig pancreas transplantation.
Witzigmann H; Ludwig S; Armann B; Gäbel G; Teupser D; Kratzsch J; Pietsch UC; Tannapfel A; Geissler F; Hauss J; Uhlmann D
Ann Surg; 2003 Aug; 238(2):264-74. PubMed ID: 12894021
[TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor antagonists: a new therapeutic option for improving the outcome after solid organ transplantation?
Göttmann U; van der Woude FJ; Braun C
Curr Vasc Pharmacol; 2003 Oct; 1(3):281-99. PubMed ID: 15320475
[TBL] [Abstract][Full Text] [Related]
15. Role of endothelin in cardiovascular disease.
Agapitov AV; Haynes WG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741
[TBL] [Abstract][Full Text] [Related]
16. [Minimization or avoidance of calcineurin inhibitors after renal transplantation].
Xue C; Ji ZG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Jun; 31(3):280-3. PubMed ID: 19621509
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1, endothelin-3 and their receptors (endothelin(A) and endothelin(B)) in chronic renal transplant rejection in rats.
Deng DX; Jiang J; Garcia B; Zhong R; Chakrabarti S
Transpl Int; 2000; 13(3):175-82. PubMed ID: 10935699
[TBL] [Abstract][Full Text] [Related]
18. Endothelin as a clinical target in the treatment of systemic hypertension.
Prasad VS; Palaniswamy C; Frishman WH
Cardiol Rev; 2009; 17(4):181-91. PubMed ID: 19525680
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelins in animal models of hypertension: focus on cardiovascular protection.
Moreau P; Schiffrin EL
Can J Physiol Pharmacol; 2003 Jun; 81(6):511-21. PubMed ID: 12839263
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.
Kushwaha SS; Khalpey Z; Frantz RP; Rodeheffer RJ; Clavell AL; Daly RC; McGregor CG; Edwards BS
J Heart Lung Transplant; 2005 Dec; 24(12):2129-36. PubMed ID: 16364861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
